Search hospitals > Hawaii > Honolulu

East-West Medical Research Institute

Claim this profile
Honolulu, Hawaii 96814
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Obesity
Conducts research for COVID-19
Conducts research for Coronavirus
121 reported clinical trials
2 medical researchers
Photo of East-West Medical Research Institute in HonoluluPhoto of East-West Medical Research Institute in HonoluluPhoto of East-West Medical Research Institute in Honolulu

Summary

East-West Medical Research Institute is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, COVID-19, Coronavirus and other specialties. East-West Medical Research Institute is involved with conducting 121 clinical trials across 68 conditions. There are 2 research doctors associated with this hospital, such as Cindy H. T. Pau and David Fitz-Patrick.

Top PIs

Clinical Trials running at East-West Medical Research Institute

Obesity
Obstructive Sleep Apnea
Shingles
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Flu
Liver Disease
Fatty Liver Disease
Human
Diabetes
Image of trial facility.

CagriSema vs. Tirzepatide

for Weight Loss in Obesity

This study will look at how well CagriSema compared to Tirzepatide helps people lower their body weight. CagriSema is a new investigational medicine developed by Novo Nordisk that combines Cagrilintide and Semaglutide. CagriSema is not yet being prescribed by doctors. Participant will get injections once a week throughout the treatment period. Participant will inject the study medicine under the skin with a pen injector in the thigh, stomach, or upper arm. After a first low dose, the study medicine will be gradually increased until reaching the planned dose (2.4 mg CagriSema or 15 mg Tirzepatide). The study will last for about one and a half year for each participant.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Retatrutide

for Type 2 Diabetes and Obesity

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 37 criteria
Image of trial facility.

Retatrutide

for Obesity

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 39 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at East-West Medical Research Institute?
East-West Medical Research Institute is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Diabetes, Type 2 Diabetes, Obesity, COVID-19, Coronavirus and other specialties. East-West Medical Research Institute is involved with conducting 121 clinical trials across 68 conditions. There are 2 research doctors associated with this hospital, such as Cindy H. T. Pau and David Fitz-Patrick.